PAX8 (+)/p63 (−) Immunostaining Pattern in Renal Collecting Duct Carcinoma (CDC)
نویسندگان
چکیده
منابع مشابه
[Collecting duct renal cell carcinoma].
INTRODUCTION Bellini's renal cell collecting duct carcinoma is a rarely prevalent renal tumour, with low cancer-specific survival, although its rate of response to antiangiogenic therapies is unknown. OBJECTIVES We retrospectively revise a series of collecting duct tumours, with special emphasis on the indication of target therapies and on their results. MATERIALS AND METHODS Retrospective ...
متن کاملRenal collecting duct carcinoma in a dog.
An 8-year-old, male, mongrel dog developed severe cough and anorexia and died within 3 months. Autopsy revealed an invasive grayish-white mass in the right kidney and multiple nodules in the lungs, thoracic wall, and spleen. Histologically, the renal mass and the other nodules were mainly composed of papillotubular structures lined by oval-to-polygonal pleomorphic cells. The cells were reactive...
متن کاملManagement of Renal Collecting Duct Carcinoma
Collecting duct carcinoma (cdc) or Bellini duct carcinoma is a rare type of renal cell carcinoma (rcc) thought to originate from renal collecting duct epithelium. Three multi-institutional retrospective cdc series including 262 patients were recently published from the United States1, Europe2, and Japan3. The U.S. population–based series by Wright et al. characterized cdc epidemiology in North ...
متن کاملCollecting Duct of Bellini Renal Carcinoma
Collecting duct carcinoma or Bellini duct carcinoma is a very rare variant of kidney carcinoma, characterized by an aggressive course and an extremely poor prognosis [1-4,5]. Unlike the more common variants of renal cell carcinoma that arise from the convoluted tubules of the renal cortex, this aggressive malignancy is derived from the renal medulla, possibly from the distal collecting ducts of...
متن کاملGenomic profiling of collecting duct renal carcinoma
duct renal carcinoma (CDC) or Bellini cancer is a rare subtype of renal cell carcinoma (RCC), initiated from distal part of the collecting ducts. At the time of diagnosis, about 50% of the patients are found to have metastases and a poor outcome. The response to chemotherapy in CDC patients is modest and overall survival is less than 1 year. Several regimens that include methotrexate, vinblasti...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: American Journal of Surgical Pathology
سال: 2010
ISSN: 0147-5185
DOI: 10.1097/pas.0b013e3181dc5e8a